jm's Adventure with Multiple Myeloma: Carfilzomib (Kyprolis) Authorization Completed - October 26 2012

Total Pageviews

Click on photos to make them larger and clearer. New to the blog, the oldest or beginning entries are at the bottom and you read upwards to the most recent date or go to Labels and begin with Entry 1. Use the alpha Labels on right to find topics of most interest to you.

Friday, October 26, 2012

Carfilzomib (Kyprolis) Authorization Completed - October 26 2012

I knew I posted a little early today - RN Peggy from St. Luke's Hospital MSTI in Twin Falls just told me that my carfilzomib has my health insurance authorization and will be ready for me Tuesday 30 October 2012 and 31 October 2012. I will get it intravenously 2 days in a row! If my Revlimid really arrives Monday 29 Oct 2012 - I'll start that for 21 days on 7 days off 30 October 2012 too. 

The reason the authorization process takes so long is probably related to the cost of the drug.

"Onyx announced the price of Kyprolis (carfilzomib) on 20 July 2012. The drug will cost $10,000 per 28-day cycle at the recommended dose for a patient of average size.
At that price and based on FDA-approved dosing schedules, Kyprolis will be the most expensive drug approved in the U.S. for multiple myeloma.
In comparison, Velcade costs between $4,000 to $8,000 per 28-day period, depending on the frequency of dosing, and Revlimid costs $7,900 per 28-day period at the FDA-approved 21-out-of-28-day dosing." From:

Things may be looking up for me if I don't have a heart attack from it  !

1 comment:

  1. Things are definitely looking up for you! Keep walking! I hear it is 19 degrees in Mackay today. You may have to dress like an Eskimo!